Pharmos (PARS) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Pharmos (PARS)

An SI Board Since October 1998

Posts	SubjectMarks	Bans	Symbol
1386	42	0	PARS

Emcee: Dr. John M. de Castro	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
736	Pharmos has announced in the past a line of credit up to 10million. No more f	yosi s	-	4/27/1999
735	Hi David, Hence 600 shares = approx what? 480,000 shares @ $1.25. I cannot	BRAVEHEART	-	4/27/1999
734	I Correct myself there are 600 Shares left as of today	David Israel-Rosen	-	4/27/1999
733	There were 5000 preferred shares, at 1000$ each. when conversion occurs they co	yosi s	-	4/27/1999
732	David, There were only 5,000 preferred shares issued. Please clarify your 600,0	Dr. John M. de Castro	-	4/27/1999
731	As you might expect given the Short Position there are 600,000 CC pref Shares	David Israel-Rosen	-	4/27/1999
730	That's a -4.2% change in Short Interest from March on average daily vol. of	Rick Strange	-	4/27/1999
729	There are 928,437 shares of pars short. What dos it tell us about CC Converts	David Israel-Rosen	-	4/26/1999
728	To estimate future share value is a quit difficult job. There are so many var	sam_b	-	4/26/1999
727		David Israel-Rosen	-	4/25/1999
726	Thank you... <eom>	cm	-	4/24/1999
725	Last I spoke with IR at PARS CC still had not fully converted, though they di	yosi s	-	4/24/1999
724	There Is A Yahoo! PARS Poster... Who claims that CC is still in control of the	cm	-	4/24/1999
723	Arnie...thanks for the post. I am learning the "pitfalls" as I post.	Ron	-	4/23/1999
722	Phase 1 is not so expensive and yet it takes time. Phase 2 is a bit more cost	yosi s	-	4/23/1999
721	I would think that the company would want to try and preserve cash and get HU-2	LLCF	-	4/23/1999
720	Check out the unofficial web site of Pharmos at: geocities.com	David Israel-Rosen	-	4/23/1999
719	Tamoxiphen analog is at preclinical stage at this point. Pharmos stated that th	yosi s	-	4/23/1999
718	Yosi: I'm sure you didn't mean to imply to Ron that approval for Pars &	arnie h	-	4/23/1999
717	YOSI...thank you for the reply.	Ron	-	4/23/1999
716	The only thing that PARS tamoxiphen analog act as antiangiogenesis. And in an	yosi s	-	4/22/1999
715	I assume you mean tamoxifen. The problem, of course, is that everyone has a &q	tommysdad	-	4/22/1999
714	Tamoxiphen They did not start phase 1 study yet. How long it will take ?. De	yosi s	-	4/22/1999
713	Roughly how long away is PAR's tamoxophin analogue from FDA approval? Than	Ron	-	4/22/1999
712	Once HU 211 partner is in, this will create a number of important events. Cas	yosi s	-	4/22/1999

Go to reply# or date (mm/dd/yy):